Compare RLMD & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLMD | BWMX |
|---|---|---|
| Founded | 2004 | 1995 |
| Country | United States | Mexico |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.9M | 644.3M |
| IPO Year | 2012 | 2019 |
| Metric | RLMD | BWMX |
|---|---|---|
| Price | $5.93 | $18.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $12.40 | ★ $27.83 |
| AVG Volume (30 Days) | ★ 925.0K | 68.1K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 9.11% |
| EPS Growth | ★ 45.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | $18.17 |
| Revenue Next Year | N/A | $25.68 |
| P/E Ratio | ★ N/A | $12.54 |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $0.52 | $7.80 |
| 52 Week High | $8.00 | $19.79 |
| Indicator | RLMD | BWMX |
|---|---|---|
| Relative Strength Index (RSI) | 32.00 | 60.72 |
| Support Level | $5.68 | $16.04 |
| Resistance Level | $7.46 | $19.43 |
| Average True Range (ATR) | 0.41 | 0.67 |
| MACD | -0.14 | 0.21 |
| Stochastic Oscillator | 5.11 | 66.76 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Betterware de Mexico SAPI de CV is a company in the consumer product goods industry focused on home organization and beauty and personal care products, commercialized through person-to-person selling. The Group operates through two segments: Home organization under the Betterware brand, including kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, bedroom and wellness. Products are sold through catalogues and distributed through distributors and associates. The Beauty and personal care (B&PC) segment under the JAFRA brand, which generates maximum revenue, includes fragrance, color, skin care and toiletries, distributed through leaders and consultants. The Group operates in Mexico, which generates maximum revenue, the United States and Latam.